SIC
VKTX icon

Salem Investment Counselors’s Viking Therapeutics VKTX Stock Holding History

Salem Investment Counselors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.3K Hold
2,288
– – ﹤0.01% 519
2026
Q1 		$74.5K Buy
+2,288
New +$73.5K ﹤0.01% 525
2025
Q4 		– Sell
-2,825
Closed -$74.2K – 1116
2025
Q3 		$74.2K Hold
2,825
– – ﹤0.01% 523
2025
Q2 		$74.9K Sell
2,825
-225
-7% -$5.92K ﹤0.01% 508
2025
Q1 		$73.7K Sell
3,050
-239
-7% -$7.55K ﹤0.01% 505
2024
Q4 		$132K Buy
3,289
+2,789
+558% +$159K ﹤0.01% 414
2024
Q3 		$31.7K Buy
+500
New +$29.3K ﹤0.01% 673
2024
Q1 		– Sell
-66,530
Closed -$1.24M – 1231
2023
Q4 		$1.24M Buy
+66,530
New +$870K 0.04% 172

Other funds holding VKTX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Salem Investment Counselors's VKTX Position: Q2 2026 in Review

Salem Investment Counselors held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 2,288 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Salem Investment Counselors first reported a position in VKTX in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.24M in Q4 2023. 169 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Salem Investment Counselors held 2,288 shares of Viking Therapeutics worth $89.3K as of Q2 2026.
  • Salem Investment Counselors left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #519 holding.
  • Salem Investment Counselors first reported a position in Viking Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Salem Investment Counselors's Viking Therapeutics position peaked at $1.24M in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.